TRAW
Traws Pharma, Inc.
Latest Form 4:Purchase$998KbyORBIMED ADVISORS LLC (10% Owner) · filed Apr 29, 2026
Traws Pharma, Inc. (TRAW) has 11 SEC Form 4 filings (11 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Apr 29, 2026.
Insiders have net bought $998K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Iain D. Dukes
- Employees:7
- HQ:Newtown, PA, US
- IPO:2013-07-25
Insider Buying
$998K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
| Source | ||||||
|---|---|---|---|---|---|---|
| 10% Owner | Purchase | 597,729 | $998K | Apr 29 | SEC ↗ |
Related companies
Traws Pharma, Inc. is in the Healthcare sector.